Klinische Studien zur Virusassoziiertes hämophagozytisches Syndrom

Bedingungen: Chediak-Higashi Syndrome; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; Virus-Associated Hemophagocytic Syndrome

Bedingungen: Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; X-linked Agammaglobulinemia; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; X-linked Hyper IgM Syndrome; Severe Combined Immunodeficiency; Leukocyte Adhesion Deficiency Syndrome; Virus-Associated Hemophagocytic Syndrome

Bedingungen: Hemophagocytic Lymphohistiocytosis

Bedingungen: Hemophagocytic Lymphohistiocytosis

Bedingungen: EBV Infection

Bedingungen: Epstein-Barr Virus (EBV)-Associated Diseases; EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD); EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (AID LPD); EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (CNS PTLD); EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD); Solid Organ Transplant Complications; Lymphoproliferative Disorders; Allogeneic Hematopoietic Cell Transplant; Stem Cell Transplant Complications; EBV+ Sarcomas; Leiomyosarcoma; Chronic Active Epstein-Barr Virus (CAEBV); Chronic Active Epstein-Barr Virus With Hemophagocytic Lymphohistiocytosis (HLH); Lymphohistiocytosis, Hemophagocytic